BCFA suppresses LPS induced IL-8 mRNA expression in human intestinal epithelial cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 116, Issue , 2017, Pages 27-31

  Yan, Y ^a,b   Wang, Z ^b   Greenwald, J ^b   Kothapalli, K S D ^b   Park, H G ^b   Liu, R ^a   Mendralla, E ^b   Lawrence, P ^b   Wang, X ^a   Brenna, J T ^b  

^a JIANGNAN UNIVERSITY   (China)

^b Cornell University ^*  (United States)

Author keywords

BCFA; Caco 2 cells; IL 8; Inflammation

Indexed keywords

BRANCHED CHAIN FATTY ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; IL8 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; BRANCHED CHAIN FATTY ACID; CACO-2 CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; FATTY ACID ANALYSIS; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; IL 8 GENE; INTESTINE EPITHELIUM CELL; LIPID STORAGE; NFKB GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TLR 4 GENE; UPREGULATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; IMMUNOLOGY; INTESTINE; METABOLISM; SIGNAL TRANSDUCTION;

CACO-2 CELLS; CELL SURVIVAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EPITHELIAL CELLS; FATTY ACIDS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; INTESTINES; LIPOPOLYSACCHARIDES; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 85007174621     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2016.12.001     Document Type: Article

References (35)

1. [1] Fiocchi, C., Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998), 182–205.
2. [2] Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J., Desreumaux, P., Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360 (2002), 1410–1418.
3. [3] Podolsky, D.K., Inflammatory bowel disease. New Engl. J. Med. 325 (1991), 928–937.
4. [4] Lakatos, P.L., Environmental factors affecting inflammatory bowel disease: have we made progress?. Dig. Dis. 27 (2009), 215–225.
5. [5] Ghosh, S., Shand, A., Ferguson, A., Ulcerative colitis. Br. Med. J. 320 (2000), 1119–1123.
6. [6] Chen, W., Esselman, W.J., Jump, D.B., Busik, J.V., Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Investig. Ophthalmol. Vis. Sci. 46 (2005), 4342–4347.
7. [7] Marion-Letellier, R., Butler, M., Déchelotte, P., Playford, R.J., Ghosh, S., Comparison of cytokine modulation by natural peroxisome proliferator–activated receptor γ ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells—potential for dietary modulation of peroxisome proliferator–activated receptor γ in intestinal inflammation. Am. J. Clin. Nutr. 87 (2008), 939–948.
8. [8] De Caterina, R., Cybulsky, M.I., Clinton, S.K., Gimbrone, M.A., Libby, P., The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 14 (1994), 1829–1836.
9. [9] Tanaka, S., Saitoh, O., Tabata, K., Matsuse, R., Kojima, K., Sugi, K., Nakagawa, K., Kayazawa, M., Teranishi, T., Uchida, K., Medium-chain fatty acids stimulate interleukin-8 production in Caco-2 cells with different mechanisms from long-chain fatty acids1. J. Gastroenterol. Hepatol. 16 (2001), 748–754.
10. [10] Ajuwon, K.M., Spurlock, M.E., Palmitate activates the NF-κB transcription factor and induces IL-6 and TNFα expression in 3T3-L1 adipocytes. J. Nutr. 135 (2005), 1841–1846.
11. [11] Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid–induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 84–91.
12. [12] Ran-Ressler, R.R., Devapatla, S., Lawrence, P., Brenna, J.T., Branched chain fatty acids are constituents of the normal healthy newborn gastrointestinal tract. Pediatr. Res. 64 (2008), 605–609.
13. [13] Ran-Ressler, R.R., Sim, D., Donnell-Megaro, A.M.O., Bauman, D.E., Barbano, D.M., Brenna, J.T., Branched chain fatty acid content of United States retail cow's milk and implications for dietary intake. Lipids 46 (2011), 569–576.
14. [14] Ran-Ressler, R.R., Khailova, L., Arganbright, K.M., Adkins-Rieck, C.K., Jouni, Z.E., Koren, O., Ley, R.E., Brenna, J.T., Dvorak, B., Branched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model. PLoS One, 6, 2011, e29032.
15. [15] Kniazeva, M., Crawford, Q.T., Seiber, M., Wang, C.-Y., Han, M., Monomethyl branched-chain fatty acids play an essential role in Caenorhabditis elegans development. PLoS Biol., 2, 2004, e257.
16. [16] Kniazeva, M., Euler, T., Han, M., A branched-chain fatty acid is involved in post-embryonic growth control in parallel to the insulin receptor pathway and its biosynthesis is feedback-regulated in C. elegans. Genes Dev. 22 (2008), 2102–2110.
17. [17] Yang, Z., Liu, S., Chen, X., Chen, H., Huang, M., Zheng, J., Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty acid, 13-methyltetradecanoic acid. Cancer Res. 60 (2000), 505–509.
18. [18] Wongtangtintharn, S., Oku, H., Iwasaki, H., Toda, T., Effect of branched-chain fatty acids on fatty acid biosynthesis of human breast cancer cells. J. Nutr. Sci. Vitaminol. 50 (2004), 137–143.
19. [19] Qin, X., Park, H.G., Zhang, J.Y., Lawrence, P., Liu, G., Subramanian, N., Kothapalli, K.S., Brenna, J.T., Brown but not white adipose cells synthesize omega-3 docosahexaenoic acid in culture. Prostaglandins Leukot. Essent. Fat. Acids (PLEFA) 104 (2016), 19–24.
20. [20] Park, H.G., Park, W.J., Kothapalli, K.S., Brenna, J.T., The fatty acid desaturase 2 (FADS2) gene product catalyzes Δ4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells. FASEB J. 29 (2015), 3911–3919.
21. [21] Garcés, R., Mancha, M., One-step lipid extraction and fatty acid methyl esters preparation from fresh plant tissues. Anal. Biochem. 211 (1993), 139–143.
22. [22] Lawrence, P., Brenna, J.T., Acetonitrile covalent adduct chemical ionization mass spectrometry for double bond localization in non-methylene-interrupted polyene fatty acid methyl esters. Anal. Chem. 78 (2006), 1312–1317.
23. [23] Van Pelt, C.K., Brenna, J.T., Acetonitrile chemical ionization tandem mass spectrometry to locate double bonds in polyunsaturated fatty acid methyl esters. Anal. Chem. 71 (1999), 1981–1989.
24. [24] McKay, D., Philpott, D., Perdue, M., Review article: in vitro models in inflammatory bowel disease research—a critical review. Aliment. Pharmacol. Ther. 11 (1997), 70–80.
25. [25] Fusunyan, R.D., Quinn, J.J., Ohno, Y., MacDermott, R.P., Sanderson, I.R., Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide1. Pediatr. Res. 43 (1998), 84–90.
26. [26] Ogle, C.K., Guo, X., Hasselgren, P.-O., Ogle, J.D., Alexander, J.W., The gut as a source of inflammatory cytokines after stimulation with endotoxin. Eur. J. Surg.= Acta Chir. 163 (1997), 45–51.
27. [27] Haller, D., Bode, C., Hammes, W., Pfeifer, A., Schiffrin, E., Blum, S., Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47 (2000), 79–87.
28. [28] Dingess, C.J.V. Kelly A., Ollberding, Nicholas J., Davidson, Barbara S., Woo, Jessica G., Summer, Suzanne, Peng, Yongmei M., Guerrero, M. Lourdes, Ruiz-Palacios, Guillermo M., Ran-Ressler, Rinat R., McMahon, Robert J., Brenna, J. Thomas, Morrow, Ardythe L., Branched chain fatty acid composition of human milk and the impact of maternal diet: the global exploration of human milk (GEHM) study. Am. J. Clin. Nutr., 2016 pii: ajcn132464. [Epub ahead of print]. PMID: 27903517.
29. [29] Brenna, J.T., Varamini, B., Jensen, R.G., Diersen-Schade, D.A., Boettcher, J.A., Arterburn, L.M., Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am. J. Clin. Nutr. 85 (2007), 1457–1464.
30. [30] Izutani, R., Loh, E.Y., Reinecker, H.C., Ohno, Y., Fusunyan, R.D., Lichtenstein, G.R., Rombeau, J.L., MacDermott, R.P., Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells. Inflamm. Bowel Dis. 1 (1995), 37–47.
31. [31] Eckmann, L., Kagnoff, M., Fierer, J., Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect. Immun. 61 (1993), 4569–4574.
32. [32] Eckmann, L., Jung, H.C., Schurer-Maly, C., Panja, A., Morzycka-Wroblewska, E., Kagnoff, M.F., Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 105 (1993), 1689–1697.
33. [33] Chow, J.C., Young, D.W., Golenbock, D.T., Christ, W.J., Gusovsky, F., Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274 (1999), 10689–10692.
34. [34] Lu, Y.-C., Yeh, W.-C., Ohashi, P.S., LPS/TLR4 signal transduction pathway. Cytokine 42 (2008), 145–151.
35. [35] Manček-Keber, M., Jerala, R., Postulates for validating TLR4 agonists. Eur. J. Immunol. 45 (2015), 356–370.